
Dr. Amy C. Moore
@acmoorephd
Internationally-recognized cancer research advocate and KOL. Director, Patient Engagement & Advocacy @SMMT_TX. Views = mine.
ID: 1085572952647622657
16-01-2019 16:22:15
14,14K Tweet
4,4K Followers
4,4K Following



We are grateful for Dr. Amy C. Moore and her tremendous & steadfast advocacy! We see so many #breathtakingmoments! #hope #researchmatters


So wonderful to see all of these amazing #lungcancer advocates at #ASCO25! The White Ribbon Project™ #LCSM


Can't wait for this new LungCancerRx 🫁💊 podcast with Jill Feldman of the EGFR Resisters! Congratulations to Aakash Desai, MD, MPH, FASCO Fawzi Abu Rous, MD and Eric K. Singhi, MD for this new collaboration! #LCSM

The first two episodes of the LungCancerRx 🫁💊 podcast will be released this Friday, June 13th! Recording the first two episodes live with Eric K. Singhi, MD Fawzi Abu Rous, MD & Aakash Desai, MD, MPH, FASCO was incredible - one of the most real, honest and fun conversations I've had! These are the conversations

Data from Lung Cancer Europe from patients and care partners impacted by oncogene-driven lung cancers find: 🧠 Only 1 in 4 people w oncogene-driven #lungcancer in Europe fully understand their diagnosis. 🗣 98% want a voice in treatment decisions — but only half feel heard. More 👇



Dr. Christian Rolfo is a dear colleague and friend. We have worked together on a large NCI project studying #COVID and #lungcancer, collaborated as part of International Society of Liquid Biopsy, worked together as part of the IASLC Academy and surveyed global biomarker testing in patients. #LCSM

An intimate look inside a #lungcancer patient's journey that will help you be a better #oncologist. #LungCancerRx podcast drops TOMORROW on Oncology News Central w/ Eric K. Singhi, MD Fawzi Abu Rous, MD Aakash Desai, MD, MPH, FASCO Jill Feldman EGFR Resisters #lungcancer #cancer #podcast #oncology #ASCO25

A team of researchers, led by principal investigator and thoracic oncologist Narjust Florez, MD, FASCO, associate director of our Cancer Care Equity Program, launch a first-of-its-kind study to use a novel blood test to identify people who have never used tobacco but are at a high risk of


Thank you so much Yvonne Diaz for our discussion and being an outstanding model of how patients can push the research forward. The more we work together the better the treatments become and the more likely we achieve cures!

Great interview on LungCancerRx 🫁💊 with Jill Feldman on her #lungcancer experience and path to becoming a leader in #patientadvocacy. EGFR Resisters #LCSM

The LungCancerRx 🫁💊 podcast is live! 🎧 We talked about empowerment, the importance of communication, and the lived experience - not just the diagnosis, but the impact, decisions, scanxiety, etc. I've told my story many times in many settings. This was different because my family

